Tofil NM - Search Results

1

The use of recombinant factor VIIa in a patient with Noonan syndrome and life-threatening bleeding.

Tofil NM, Winkler MK, Watts RG, Noonan J. Tofil NM, et al. Pediatr Crit Care Med. 2005 May;6(3):352-4. doi: 10.1097/01.PCC.0000160656.71424.D1. Pediatr Crit Care Med. 2005. PMID: 15857538

2

Fatal hypermagnesemia caused by an Epsom salt enema: a case illustration.

Tofil NM, Benner KW, Winkler MK. Tofil NM, et al. South Med J. 2005 Feb;98(2):253-6. doi: 10.1097/01.SMJ.0000145307.80421.4B. South Med J. 2005. PMID: 15759964

3

The use of enteral naloxone to treat opioid-induced constipation in a pediatric intensive care unit.

Tofil NM, Benner KW, Faro SJ, Winkler MK. Tofil NM, et al. Pediatr Crit Care Med. 2006 May;7(3):252-4. doi: 10.1097/01.PCC.0000216421.72002.09. Pediatr Crit Care Med. 2006. PMID: 16575353

4

Deep sedation with propofol in patients with Rett syndrome.

Tofil NM, Buckmaster MA, Winkler MK, Callans BH, Islam MP, Percy AK. Tofil NM, et al. J Child Neurol. 2006 Mar;21(3):210-3. doi: 10.2310/7010.2006.00051. J Child Neurol. 2006. PMID: 16901422

5

Deep sedation with propofol in patients with Rett syndrome.

Tofil NM, Buckmaster MA, Winkler MK, Callans BH, Islam MP, Percy AK. Tofil NM, et al. J Child Neurol. 2006 Oct;21(10):857-60. doi: 10.1177/08830738060210100101. J Child Neurol. 2006. PMID: 17005101 Clinical Trial.

6

Is hyperglycemia really harmful? A critical appraisal of "Persistent hyperglycemia in critically ill children" by Faustino and Apkon (J Pediatr 2005; 146:30-34).

Kong MY, Alten J, Tofil N. Kong MY, et al. Pediatr Crit Care Med. 2007 Sep;8(5):482-5. doi: 10.1097/01.PCC.0000282778.86088.9D. Pediatr Crit Care Med. 2007. PMID: 17693916 Review.

7

Histamine 2 receptor antagonists vs intravenous proton pump inhibitors in a pediatric intensive care unit: a comparison of gastric pH.

Tofil NM, Benner KW, Fuller MP, Winkler MK. Tofil NM, et al. J Crit Care. 2008 Sep;23(3):416-21. doi: 10.1016/j.jcrc.2007.10.038. J Crit Care. 2008. PMID: 18725049 Clinical Trial.

8

Pediatric off-label use of recombinant factor VIIa.

Alten JA, Benner K, Green K, Toole B, Tofil NM, Winkler MK. Alten JA, et al. Among authors: tofil nm. Pediatrics. 2009 Mar;123(3):1066-72. doi: 10.1542/peds.2008-1685. Pediatrics. 2009. PMID: 19255041

9

Outcomes of critically ill children requiring continuous renal replacement therapy.

Hayes LW, Oster RA, Tofil NM, Tolwani AJ. Hayes LW, et al. Among authors: tofil nm. J Crit Care. 2009 Sep;24(3):394-400. doi: 10.1016/j.jcrc.2008.12.017. Epub 2009 Mar 27. J Crit Care. 2009. PMID: 19327959

10

Prevalence of adverse events in pediatric intensive care units in the United States.

Agarwal S, Classen D, Larsen G, Tofil NM, Hayes LW, Sullivan JE, Storgion SA, Coopes BJ, Craig V, Jaderlund C, Bisarya H, Parast L, Sharek P. Agarwal S, et al. Among authors: tofil nm. Pediatr Crit Care Med. 2010 Sep;11(5):568-78. doi: 10.1097/PCC.0b013e3181d8e405. Pediatr Crit Care Med. 2010. PMID: 20308932

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

88 results

Search Page